Senior insider sale
Global Head of R&D at BEONE MEDICINES LTD. — senior position signals high conviction
$1.17M
4.36K shares
What this filing means
WANG LAI plans to sell 4.36K shares of BEONE MEDICINES LTD. valued at approximately $1.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/23/2026ACC: 0001950047-26-006417
Officer· Global Head of R&D
Since Apr 2021
4.36K
Shares to sell
$1.17M
Approx. market value
1.07K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Not Applicable
6/22/2026
1.07KTotal acquired1.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/22/2026 | Restricted Stock Vesting Under a Registered Plan Not Applicable | 1.07K | — |
| Total | 1.07K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.17K
Market value
$310.2K
6/16/2026
—Completed
Units to sell
756.00
Market value
$197.6K
6/11/2026
—Completed
Units to sell
1.37K
Market value
$368.2K
6/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.07K
Market value
$295.6K
6/23/2026
Total
Units
4.36K
Value
$1.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/16/2026 | 1.17K | $310.2K | — | Completed |
6/11/2026 | 756.00 | $197.6K | — | Completed |
6/8/2026 | 1.37K | $368.2K | — | Completed |
| Planned — Approximate Date | ||||
6/23/2026 | 1.07K | $295.6K | NASDAQ | Planned |
| Total | 4.36K | $1.17M | ||